Home Tags Pfizer/BioNTech COVID-19 vaccine

Tag: Pfizer/BioNTech COVID-19 vaccine

“Health Alert on mRNA COVID-19 Vaccine Safety” from Florida and State...

On the cover image Florida Governor Ron DeSantis beside Joseph A. Ladapo State Surgeon General All links to Gospa News articles have been added aftermath for...

VITAL! Pfizer mRNA Vaccines: Risks of Pulmonary Embolism, Myocarditis, Blood Clots....

by Fabio Giuseppe Carlo Carisio VERSIONE IN ITALIANO In the lates weeks the British Medical Journal blamed the Food and Drug Administration because had concealed the...

Serious Injuries and Deaths due to Vaccines’ Adverse Reactions: Italian Judge...

The deadly danger of experimental gene serums based on mRNA is highlighted in a “historical” sentence by Court of Florence

The Study that Changed Covid Vaccines History. Pfizer mRNA Serum can...

by Fabio Giuseppe Carlo Carisio for VT Europe VERSIONE IN ITALIANO All the linked articles in Italian are available in simultaneous machine translation in English -...

Worrying German Study on Covid-19 Vaccination Boosters: “Pfizer Bivalent caused more...

Wuerzburg University Hospital, in Germany, is sounding a very worrying alarm: the new bivalent boosters cause more and more serious adverse reactions than those not updated for the two Omicron variants

Get Your COVID-19 Vaccine Boosters

Although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it’s clear from these preliminary data that protection is improved with a third dose of Pfizer vaccine.

FDA Approves Emergency Use Authorization for Pfizer/BioNTech COVID-19 Vaccine

The rollout of Covid-19 vaccine could then begin in the United States in a matter of days

Vaccine (V) Day to Begin in U.K. 12/8/2020

Governments and health agencies around the world will be monitoring the British vaccination program

Livestream of FDA Advisory Committee to Discuss Pfizer/BioNTech COVID-19 Vaccine Candidate

FDA has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10